Matrix effect of commercially available direct oral anticoagulant standards: a look through the limits and the need for standardization of current calibrators

Jonathan Douxfils, Hélène Legrand, Anne-Laure Sennesael, Sarah Lessire, Anne-Sophie Dincq, Anne-Sophie Larock, Bernard Chatelain, Jean-Michel Dogne, François Mullier

Research output: Contribution in Book/Catalog/Report/Conference proceedingConference contribution

Original languageEnglish
Title of host publicationAbstracts of the 62nd Annual Meeting of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis May 25–28, 2016
Pages30
Number of pages1
DOIs
Publication statusPublished - 13 May 2016
Event62nd Annual SSC Meeting of the International Society of Thrombosis and Hemostasis - Le Corum, Montpellier, France
Duration: 25 May 201628 May 2016

Conference

Conference62nd Annual SSC Meeting of the International Society of Thrombosis and Hemostasis
CountryFrance
CityMontpellier
Period25/05/1628/05/16

Cite this

Douxfils, J., Legrand, H., Sennesael, A-L., Lessire, S., Dincq, A-S., Larock, A-S., ... Mullier, F. (2016). Matrix effect of commercially available direct oral anticoagulant standards: a look through the limits and the need for standardization of current calibrators. In Abstracts of the 62nd Annual Meeting of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis May 25–28, 2016 (pp. 30). [CA-54] https://doi.org/10.1111/jth.13325